Press Releases
21 November 2019
LINKÖPING, Sweden, Nov. 21, 2019 /PRNewswire/ -- AMRA Medical announces it has entered into a new collaboration with Hamad Medical Corporation. This collaboration further develops AMRA Medica
Read more...NEWTOWN, Pa., Nov. 21, 2019 /PRNewswire/ -- STI Pharma, LLC today announced that it has appointed Frank Mullery President and CCO.
Read more...21 November 2019
NEWTOWN, Pa., Nov. 21, 2019 /PRNewswire/ -- STI Pharma, LLC today announced the US launch of Carmustine for Injection, USP: 1 Kit (100mg per Vial & Diluent), a generic version of AVET's (formerly Heritage) BiCNU®. STI received the final approval from the US Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for this product.
Read more...21 November 2019
SAN DIEGO, Nov. 21, 2019 /PRNewswire/ -- Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable informat
Read more...21 November 2019
WASHINGTON, Nov. 21, 2019 /PRNewswire/ -- 60 Degrees Pharmaceuticals (60P) has initiated distribution of Arakoda™ (tafenoquine) into the US healthcare marketplace. This s
Read more...BOSTON, Nov. 21, 2019 /PRNewswire/ -- Blue Cross Blue Shield of Massachusetts ("Blue Cross") today announced a new bene
Read more...21 November 2019
Results presented at the 3rd SNO-SCIDOT Joint Conference show 12-month survival benefit of over 111% in patients over-expressing the IL-4 receptor TORONTO and HOUSTON, Nov. 21, 2019 /PRNewswire/ - Medicenna Therapeutics Corp. (TSX: MDNA, OTCQB: MDNAF), a clinical stage immuno-oncology c
Read more...21 November 2019
SAN FRANCISCO, Nov. 21, 2019 /PRNewswire/ -- Stride, the world's leading benefits platform for independent workers, today shared data revealing that 23% of rideshare and delivery driver gig workers have enrolled in qualified health insurance plans costing them less than $1 per month, and 40% are enrolling in plans for less than
Read more...21 November 2019
NESS-ZIONA, Israel, Nov. 21, 2019 /PRNewswire/ -- Tikcro Technologies Ltd. (OTCQB: TIKRF), a pre-clinical stage developer of antibodies for cancer immune-therapy, today reported its financial results for the third quarter ended September 30, 2019."We have concluded the pre-clinical development stage of
Read more...21 November 2019
BOSTON, Nov. 21, 2019 /PRNewswire/ -- Silk Medical Aesthetics, a spin-off of green chemistry company Evolved By Nature, today announced it has finishe
Read more...
